{
    "title": "UPDATE 1-Novo Nordisk's diabetes drug succeeds in key trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4798108/UPDATE-1-Novo-Nordisks-diabetes-drug-succeeds-key-trial.html",
    "date": "2017-08-17",
    "keywords": [
        "drug",
        "trial",
        "type",
        "semaglutide",
        "wednesday",
        "standard",
        "therapy",
        "novo",
        "nordisk",
        "retinopathy",
        "analyst",
        "goal",
        "latestage",
        "stage",
        "addition",
        "standardofcare",
        "metformin",
        "body",
        "weight",
        "obesity",
        "percent",
        "increase",
        "loss",
        "butler",
        "number",
        "event",
        "potential",
        "treatment",
        "company",
        "belong",
        "category",
        "hormone",
        "production",
        "absorption",
        "insulin",
        "pricing",
        "factor",
        "space",
        "heffrey",
        "holford",
        "client",
        "note",
        "lillys",
        "dulaglutide",
        "brand",
        "name",
        "trulicity",
        "growth",
        "success",
        "quarter",
        "accounting",
        "half",
        "product",
        "leadership",
        "position",
        "segment",
        "formulation",
        "market",
        "favor",
        "term",
        "reporting",
        "divya",
        "grover",
        "bengaluru",
        "editing",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}